europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

What if we used biology instead of chemistry for manufacturing?

01/02/2020
FACTSHEET
What if we used biology instead of chemistry for manufacturing?

Learning from life’s inbuilt sustainability

Solution: Using enzymes to produce chemicals in a biological way.

Did you know?
The only thing enzymes do is position molecules in such a way that they react spontaneously and yield the desired compound.

Today, many essential chemicals are derived from petroleum. This is an extractive rather than circular process and generates unwanted by-products, such as carbon dioxide. Hydrogen peroxide is one example of a chemical produced from petroleum. Commonly used as a disinfectant, it is also a rocket fuel and a precursor to other chemicals. However, hydrogen peroxide requires an expensive and energy-intensive process to manufacture chemically.

In 2017, a biotech company called Solugen managed to produce hydrogen peroxide by using enzymes. Enzymes are proteins found in all living organisms that make most of the chemical reactions in the body happen. Some microorganisms have an enzyme that turns plant sugars into hydrogen peroxide, without harmful by-products and in an energy-efficient way. The founders of Solugen discovered this enzyme and successfully managed to produce it in a bioreactor. This reactor is fed with different kinds of sugars and produces the desired hydrogen peroxide, which is now being sold in the form of bio-degradable, disinfectant wipes. A strong point of the technology is its versatility. The reactor can be fed with different types of sugars depending on what is locally available - for example, cane sugar in India or beet sugar in Chile.

Essential to Solugen’s research was the use of genome editing in the form of CRISPR. This tool allows scientists to make changes to the individual letters of the genetic code in an efficient and easy way. This made it possible to create enzymes cheaply and at scale. Not just the hydrogen peroxide enzyme, but any enzyme. Using the bioreactor the company created, they also produce chemicals for the oil & gas, water treatment, industrial & consumer cleaning, and food & agriculture industries. This can help the chemical manufacturing industry become more sustainable, one enzyme at a time.

What if we used biology instead of chemistry for manufacturing?


Download
2020_01_I_F_EuropaBIO_WHATIF_solugen_V04Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Read more
19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe


Read more
19/12/2022

The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry


Read more
13/12/2022

SenseUp joins EuropaBio: leveraging the power of bio-tech for sustainable and commercially viable solutions


Read more

Important links

  • EuropaBio launches SME BioForum in Rare Diseases
  • EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

Categories in our Newsroom

Search by tags

  • Innovation
  • Excellence
  • Science
  • ATMPs
  • Healthcare Biotech
  • Industrial Biotech
  • Investment
  • EuropaBio
  • EFIB
  • Regulation
  • Rare Diseases
  • COVID-19
  • Members
  • Cancer
  • Patients
  • Patient BioForum
  • Gene & Cell Therapies
  • Accessibility
  • Intellectual Property
  • Pharmaceutical Strategy for Europe

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member